Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. Most sites in Andhra Pradesh and Telangana had FDA and/or EMA approval (297 out of a total 476 sites). ©GlobalData.

Manufacturing 130

Manufacturing Generic Drugs Contract Manufacturing Production 130

Pharmacy Checkers

NOVEMBER 21, 2019

The FDA’s capacity to evaluate new and generic drug applications and its oversight over drug manufacturing are why we have this degree of assurance. The FDA is also looked to by drug regulatory authorities in other countries for its strengths. See FDA Fact Sheet. and other high-income countries.

Generic Drugs 68

Generic Drugs Manufacturing Regulation Drugs 68

Pharmacy Checkers

DECEMBER 12, 2019

Importing medicines from countries that do not have our same strong standards could taint our medicine supply.”. The second sentence is deceptively broad: as in, yes, importing medicines from countries that do not have our “same” standards could taint our medicine supply. Not necessarily, but it could. If the U.S.

Drugs 71

Drugs Manufacturing Medicine Compliance 71

The Pharma Data

MAY 4, 2021

Internal Medicine. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Lorbrena, expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). REVENUES. . . . . . ($ in millions).

Vaccination 40

Vaccination Vaccine Production Sales 40